Stemergie Biotechnology is Biotechnology in Switzerland that focus on technology platform business. Founded in 2009. They cover business area such as developer, csc) technology platform, brain tumor, potentially further cancer indication, an unbiased identification, validation, development, treatment, researcher, large laboratory, their drug, cancer stem cell.
2009
( 15 years old in 2024 )
Technology Platform
-
64 Avenue De La Roseraie
1205 Genève
Switzerland
Private
developercsc) technology platformbrain tumorpotentially further cancer indicationan unbiased identificationvalidationdevelopmenttreatmentresearcherlarge laboratorytheir drugcancer stem cell
* We use standard office opening hours in near Stemergie Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stemergie Biotechnology is Biotechnology business from Switzerland that founded in 2009 (15 years old in 2024), Stemergie Biotechnology business is focusing on Technology Platform.
Stemergie Biotechnology headquarter office and corporate office address is located in 64 Avenue De La Roseraie 1205 Genève Switzerland.
Stemergie Biotechnology was founded in Switzerland.
In 2024, Stemergie Biotechnology is currently focus on technology platform sector.
Above is snippet of Google Trends for "technology platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stemergie Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.